Dr. Sánchez-Juan specialized as a Neurologist at the Hospital Universitario Marqués de Valdecilla. After his residency he was awarded with the Wenceslao López Albo research grant. He spent a year as a researcher in Edinburgh at the Creutzfeldt Jakob National Surveillance Unit in the United Kingdom. Later he graduated in the field of Genetic Epidemiology at the Erasmus MC University (Rotterdam, The Netherlands), where he completed his MSc and PhD. During his stay in Rotterdam, he served as Coordinator of Prion Diseases Surveillance in the Netherlands and gained valuable experience in the field of epidemiology working in the prestigious Rotterdam Study cohort. In 2011 completed his clinical training as an expert in dementia and behavioural neurology at UCSF Memory and Aging Center in San Francisco.
Dr Sánchez-Juan combines his work as clinician at the Hospital Universitario Marqués de Valdecilla with the scientific direction of the Valdecilla Biobank. He is Principal Investigator of the Dementia Research Group of University Hospital Marqués de Valdecilla at IDIVAL, co- Principal Investigator of CIBERNED group and member of the executive committee of the Dementia Genetic Spanish Consortium.
Dr Sánchez-Juan is author of more than 130 international publications indexed in Medline. The main scientific interest of Dr Sánchez-Juan are neurodegenerative diseases, particularly prion diseases and Alzheimer’s disease. His publications include first authorship in two genome-wide association studies on prion disease. He is also first or senior author of some pivotal highly cited articles in the field of prion diseases biomarkers, and he is the senior author of the current clinical diagnostic criteria for these diseases.